Anti-TNFSF5/CD40L/CD154 Antibody (Ruplizumab)
Catalog No.
F1065
Anti-TNFSF5/CD40L/CD154 Antibody (Ruplizumab)
Featured Products
Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential to be used in systemic lupus erythematosus disease research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.68 kDa
Dry ice
220651-94-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BG-9588
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P29965
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF5 / CD40L / CD154
Please avoid freeze-thaw cycles.